… with seven new appointees. Departures:  Vertex Pharmaceuticals’ longtime chief scientific officer David …

… on Vertex Pharmaceuticals. Our analysis of options history for Vertex Pharmaceuticals … 7K 307 64 About Vertex Pharmaceuticals Vertex Pharmaceuticals is a global biotechnology company … Current Position of Vertex Pharmaceuticals Currently trading with a …

… Big Names Bleed Double Digits. Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) is one … worst-performing stocks on Tuesday. Vertex Pharmaceuticals nosedived on Tuesday to hit … the year. During the quarter, Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) swung to …

US-based Vertex Pharmaceuticals has axed plans … . Following this finding, Vertex has decided not to … sodium) and Hikma Pharmaceuticals/;Kensington Pharma’s Combogesic (acetaminophen and … for the indication. Though Vertex has broken ground with Journavx …

Key Takeaways Vertex Pharmaceuticals reported a Phase … strong quarterly earnings. Shares of Vertex Pharmaceuticals (VRTX) sank 15% Tuesday … January. The news offset Vertex's better-than … 39;s big selloff, Vertex Pharmaceutical shares hovered around break- …

A Vertex Pharmaceuticals drug viewed as a successor … pain approach of Boston-based Vertex focuses on blocking sodium … time when AI is reshaping pharma, Reverba Global CEO Cheryl … with diabetic peripheral neuropathy. Vertex expects to complete enrollment in …

Bengaluru: Vertex Pharmaceuticals will stop developing its … was not statistically significant, Vertex said. The company tested … analyst David Risinger said Vertex's pain portfolio … that were above expectations. Vertex plans to prioritize testing of …

… CEO of Vertex Pharmaceuticals. In connection with earnings, Vertex announced topline … to their price targets on Vertex Pharmaceuticals following earnings announcement. Trending … analyst Greg Harrison maintained Vertex Pharmaceuticals with a Sector Perform …

Vertex Pharmaceuticals Inc.’s bad news from … , down $78.44, or 16%. Vertex rolled out top-line results …